Evidence map›Paper›PMID 35860358›Full record

ArticleFrontiers in molecular biosciences2022

Impact of Formulation Choices on the Freeze-Drying of an Interleukin-6 Reference Material.

Paul Matejtschuk, Christopher Bird, Ernest Ezeajughi, Kirsty MacLellan-Gibson, Meenu Wadhwa

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Paul MatejtschukAnalytical and Biological Sciences, NIBSC, Medicines and Healthcare Products Regulatory Agency, Potters Bar, United Kingdom.
Christopher BirdBiotherapeutics, NIBSC, Medicines and Healthcare products Regulatory Agency, Potters Bar, United Kingdom.
Ernest EzeajughiAnalytical and Biological Sciences, NIBSC, Medicines and Healthcare Products Regulatory Agency, Potters Bar, United Kingdom.
Kirsty MacLellan-GibsonAnalytical and Biological Sciences, NIBSC, Medicines and Healthcare Products Regulatory Agency, Potters Bar, United Kingdom.
Meenu WadhwaBiotherapeutics, NIBSC, Medicines and Healthcare products Regulatory Agency, Potters Bar, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Formulation is critical to successful delivery of lyophilized biologics. We have compared the impact of buffer choice and the addition of sodium chloride (a formulant often viewed as unfavorable for freeze-drying applications) on the outcome of trial lyophilization of an interleukin-6 reference material. While phosphate buffer was a preferred choice and yielded well-formed cakes associated with fair recovery of biological activity, the resultant residual moisture content was high (2-4% w/w). By inclusion of isotonic levels of NaCl, the freeze-dried appearance and process were not impaired, but the residual moisture delivered was considerably reduced to levels <1% w/w. We postulate that this is due to the presence of a more open-cake structure and support this with evidence from thermal analysis and scanning electron microscopy. This work illustrates the importance of wide ranging empirical investigation of formulation options in order to optimize freeze-drying outcomes for biologics.

Indexed as

differential scanning calorimetryformulationfreeze dryinginterleukin-6scanning electron microscopysodium chloride

Identifiers

PMID35860358
PMCPMC9289548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.